Novel germline MSH2 mutation in lynch syndrome patient surviving multiple cancers
-
* Corresponding author: Pavel Elsakov elena.jelsakova@seb.lt
Hereditary Cancer in Clinical Practice 2012, 10:1 doi:10.1186/1897-4287-10-1
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 21 Jul 2011 | |
| Reviewer's Report | Noralane Lindor | 25 Jul 2011 | |
| Reviewer's Report | Jacek Gronwald | 09 Aug 2011 | |
| Editor's comment | Editor's comment | 09 Aug 2011 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 06 Sep 2011 |
| Reviewer's Report | Noralane Lindor | 12 Sep 2011 | |
| Reviewer's Report | Jacek Gronwald | 12 Nov 2011 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 08 Dec 2011 |
| Editorial acceptance | 21 Dec 2011 | ||
| Published | 10 Jan 2012 |